Scholarlink

Praziquantel was jointly developed by Bayer AG (Elberfeld) and E. Merck (now Merck KGaA, Darmstadt) in the early 1970s. The two companies established a contractual agreement focused on human tropical medicine to formalize this partnership. Under the terms of the agreement, they cooperated on securing Intellectual Property Rights and formulating an effective filing strategy.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Proprietary Aspects of Praziquantel

  • 章节

  • 出版模式：

    开放获取

  • 发表日期：

    2026年

查看全文
  • Arno Hartmann

摘要

Praziquantel was jointly developed by Bayer AG (Elberfeld) and E. Merck (now Merck KGaA, Darmstadt) in the early 1970s. The two companies established a contractual agreement focused on human tropical medicine to formalize this partnership. Under the terms of the agreement, they cooperated on securing Intellectual Property Rights and formulating an effective filing strategy.